Delivery Order SPE2DB24D8003-SPE2DB25FJUDJ
Award Date
4/4/25
Potential Completion Date
4/7/25
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $3,351.99 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the provision of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. This award is part of Dakota Drug, Inc.'s broader Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a range of pharmaceutical products, medical supplies,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, with a ceiling value of $1,035.87, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a period of performance through February 6, 2025. Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84 and a period of performance through January 24, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, providing a wide range of pharmaceutical products, medical supplies, and...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, is a Delivery Order valued at $2,397.84 for the pharmaceutical product MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 16, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to federal agencies, particularly supporting U.S. Armed...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, with a total ceiling value of $1,188.84 and a period of performance through May 28, 2025. Dakota Drug, Inc. is a key supplier of medical products and pharmaceuticals to the U.S. Armed Forces, holding a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a ceiling value of $1,188.84. The contract has an ultimate completion date of May 20, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed-price delivery order contract worth $9,080.31 to Dakota Drug, Inc., a self-certified small disadvantaged business, for the provision of 4559106710 MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML. This contract is part of the DLA's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and medical simulation equipment from manufacturers and distributors. Dakota Drug, Inc. holds a...
The Defense Logistics Agency (DLA) awarded a $3,689.76 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business, to provide the pharmaceutical product MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. This order is part of Dakota Drug's $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment, accessories, consumables, and simulation equipment for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $2,511.38, is for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has a firm fixed price pricing type and a completion date of March 14, 2025. Dakota Drug, Inc. is also the holder of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA, identified as...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Mounjaro 2.5 mg/0.5 mL pens, with a ceiling value of $3,033.72 and a period of performance through April 29, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support...